申请人:Glaxo Group Limited
公开号:US20170281532A1
公开(公告)日:2017-10-05
The compounds of the subject invention are related to 2-substituted cephem compounds, which have a wide antimicrobial spectrum, in particular exhibit potent antimicrobial activity against beta-lactamase producing Gram negative bacteria, and pharmaceutical compositions comprising the same.